Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France-Reference-Cited by-同舟云学术

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France

Published:2021-12-02 Issue: Volume: Page:1-9
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hong Eva¹,Terrade Aude¹,Muzzi Alessandro²^ORCID,De Paola Rosita²^ORCID,Boccadifuoco Giuseppe²^ORCID,La Gaetana Rita²,Deghmane Ala-Eddine¹,Pizza Mariagrazia²^ORCID,Serino Laura²,Taha Muhamed-Kheir¹^ORCID

Affiliation:

1. Institute Pasteur, Invasive Bacterial Infections Unit, Paris, France

2. GSK, Siena, Italy

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.2004055

Reference25 articles.

1. Description and Nomenclature ofNeisseria meningitidisCapsule Locus

2. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

3. Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence

4. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016–2019 and coverage vaccine prediction;Vaccine;2024-12

2. Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010–2014;Human Vaccines & Immunotherapeutics;2024-07-22

3. 4CMenB journey to the 10-year anniversary and beyond;Human Vaccines & Immunotherapeutics;2024-07-08

4. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020;mSphere;2024-06-25

5. Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness;Expert Review of Vaccines;2023-08-25